MicroRNA Market Key Trends, New Opportunities, Analysis And Sales Revenue 2025 – 2032
According to the estimates from the American Cancer Society, 609,360 deaths from cancer were registered in 2022 alone in the US, and over 1.9 million people were newly diagnosed with cancer. In addition, the pace at which microRNA diagnostics gained ground in clinical settings brought forward developments in precision medicine of cancer. As per the microRNA market analysis, the two key factors driving the growth of the market include growing prevalence of such diseases as cancer, heart disease, and other neurological conditions worldwide and rapid developments in genomic technologies. Furthermore, besides this, miRNAs have offered excellent noninvasive biomarkers for cancer.
MicroRNA Market size was valued at USD 1.35 Billion in 2023 and is poised to grow from USD 1.52 Billion in 2024 to USD 4.04 Billion by 2032, growing at a CAGR of 12.90% during the forecast period (2025-2032).
Get Your Free Sample Report Here @ https://www.skyquestt.com/samplerequest/microrna-market
Since miRNAs play a crucial role in the post-transcriptional regulation of gene expression, they are rapidly being recognized as robust biomarkers of human disorders. Support for their utility as diagnostic and prognostic biomarkers in the form of blood is seen through their stability within serum and plasma. In addition, circulating miRNAs inside exosomes are serum biomarkers used to elucidate information regarding the immunological status in both healthy and pathological states. For instance, the concentration of microRNA-150 in the blood after lymphocyte activation sharply increases in vaccinated subjects. That lends credibility to the use of circulating microRNAs as potential indicators of immunologic status. Consequently, and expanding the business in general, prospects of using microRNA as a biomarker for a variety of diseases have an argument on its side.
MicroRNA Market Segments Analysis:
Global MicroRNA Market is segmented by Component, Application, End-use, and region.
Based on Products & Services, the market is segmented into services, and products.
Based on Application, the market is segmented into Cancer, Infectious Diseases, Immunological Disorder, Cardiovascular Disease, Neurological Disease, and Others.
Based on End-use, the market is segmented into Biotechnology & Pharmaceutical Companies, Academic & Government Research Institutes, and Others.
Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.
MicroRNA Market Key Players:
Thermo
Fisher Scientific, Inc. (US)
QIAGEN (Germany)
NanoString Technologies, Inc. (US)
Merck KGaA (Germany)
Takara Bio, Inc. (Japan)
BioGenex (US)
GeneCopoeia, Inc. (US)
New England Biolabs (US)
Agilent Technologies, Inc. (US)
Illumina, Inc. (US)
Abcam plc (UK)
Roche Holding AG (Switzerland)
Arcturus Therapeutics Ltd. (US)
Synthego Corporation (US)
Bio-Techne Corporation (US)
F. Hoffmann-La Roche Ltd. (Switzerland)
Asuragen, Inc. (US)
Cell Signaling Technology, Inc. (US)
Molecular Cloud (China)
Ribomed Biotechnologies, Inc. (US)
Sirnaomics Inc. (US)
MicroRNA Market Regional Insights:
The microRNA market outlook highlighted that in 2023, the market was dominated by North America. This is so because growth in the region of microRNA is attributed to a number of factors, such as availability of significant population of major players in the area; some of which are Merck KGaA., NanoString Technologies, Inc., and Thermo Fisher Scientific, besides others whose expenditure on R&D has increased with them trying to come up with more advanced and innovative products. In 2023, the US accounted for the highest microRNA market share in North America. Some of the prominent players of the market with headquarters based in the US are Thermo Fisher Scientific, Merck KGaA., and QIAGEN. Distribution networks form the backbone of these players. The country enjoys simple access to miRNA services and products.
What's more, it likewise covers the request and give of the promoting research concentrate in the assessed figure time frame. Explained investigation of the market players with their profile, deals examination and serious scene is given in the report. Besides, organization, joint effort and consolidations in the business are referenced for the accommodation of the investigation of the global MicroRNA industry.
Related Reports:
https://www.dreamnews.jp/press/0000317459/ https://www.skyquestt.com/report/silicon-carbide-market
Looking ahead, the MicroRNA Market is poised for continued growth, driven by evolving consumer preferences and ongoing innovations. The trend towards sustainability is expected to strengthen, with more consumers seeking products that align with their values. Additionally, the integration of advanced technologies and digital platforms will likely further enhance market accessibility and consumer engagement. The global
MicroRNA Market is a dynamic and evolving landscape, shaped by a confluence of trends and factors.
Browse Complete Report MicroRNA Market for Better Understandinghttps://www.skyquestt.com/report/microrna-market
Contact Us:
SkyQuest Technology
1 Apache Way, Westford, Massachusetts 01886
USA (+1) 351–333–4748
Email: sales@skyquestt.com
Visit Our Website: https://www.skyquestt.com/
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology. We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia Pacific."
